PMGC Holdings Inc. Reports Board Changes and Executive Compensation Updates
Ticker: ELAB · Form: 8-K · Filed: Dec 31, 2024 · CIK: 1840563
Sentiment: neutral
Topics: board-changes, executive-compensation, filing
TL;DR
PMGC Holdings Inc. shuffled its board and updated exec pay. Big changes coming?
AI Summary
PMGC Holdings Inc. announced on December 23, 2024, a change in its board of directors and executive compensation arrangements. The filing details the departure of certain directors and the election of new ones, alongside updates to the compensatory arrangements for its named executive officers. This report also includes financial statements and exhibits.
Why It Matters
Changes in a company's board and executive compensation can signal shifts in strategy, governance, or financial outlook, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Board and executive changes, coupled with financial statement filings, can indicate significant internal shifts that may affect the company's future direction and performance.
Key Players & Entities
- PMGC Holdings Inc. (company) — Registrant
- December 23, 2024 (date) — Date of earliest event reported
- 120 Newport Center Drive (address) — Business and Mail Address
- Newport Beach, CA (location) — City and State of Business Address
- Elevai Labs Inc. (company) — Former Company Name
- Reactive Medical Labs Inc. (company) — Former Company Name
FAQ
What specific changes were made to the board of directors?
The filing indicates a departure of certain directors and the election of new directors, though specific names are not detailed in the provided excerpt.
What are the key updates regarding executive compensation?
The report covers updates to the compensatory arrangements of certain officers, but the specific details of these arrangements are not provided in this excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on December 23, 2024.
What is the primary business of PMGC Holdings Inc. according to the filing?
PMGC Holdings Inc. is classified under Pharmaceutical Preparations (SIC code 2834).
What were PMGC Holdings Inc.'s former company names?
The company was formerly known as Elevai Labs Inc. and Reactive Medical Labs Inc.
Filing Stats: 470 words · 2 min read · ~2 pages · Grade level 9.6 · Accepted 2024-12-31 06:04:15
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value ELAB The Nasdaq Stock Mar
Filing Documents
- ea0225882-8k_pmgchold.htm (8-K) — 25KB
- ea022588201ex99-1_pmgchold.htm (EX-99.1) — 2KB
- 0001213900-24-113645.txt ( ) — 203KB
- elab-20241223.xsd (EX-101.SCH) — 3KB
- elab-20241223_lab.xml (EX-101.LAB) — 34KB
- elab-20241223_pre.xml (EX-101.PRE) — 22KB
- ea0225882-8k_pmgchold_htm.xml (XML) — 4KB
02 Departure of Directors or Certain Officers; Election of
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Effective as of December 23, 2024, Mr. Jordan R. Plews resigned as Director of PMGC Holdings Inc. (f/k/a Elevai Labs Inc., the "Company"). Mr. Plews' resignation was not the result of any disagreement with the Company on any matter relating to its operation, policies (including accounting or financial policies), or practices. Mr. Plews' resignation letter is filed herein as Exhibit 99.1.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. Exhibit No. Description 99.1 Jordan R. Plews Resignation Letter 104 Cover Page Interactive Data File (formatted in Inline XBRL). 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 31, 2024 PMGC Holdings Inc. By: /s/ Graydon Bensler Name: Graydon Bensler Title: Chief Executive Officer, President, and Director 2